drug price negotiations

Big Pharma’s stance on CMS drug price negotiations remains unclear

Big Pharma’s stance on CMS drug price negotiations remains unclear

Anika Sharma

Following the release of the list of drugs slated for pricing negotiations under the Inflation Reduction Act (IRA) by the ...